INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 211 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,153,765 | -38.9% | 713,261 | -25.7% | 0.01% | -38.1% |
| Q2 2023 | $60,783,401 | +142229.9% | 959,940 | +21.7% | 0.02% | +31.2% |
| Q1 2023 | $42,706 | +9.6% | 788,664 | +7.1% | 0.02% | +6.7% |
| Q4 2022 | $38,983 | -99.9% | 736,648 | +31.8% | 0.02% | +36.4% |
| Q3 2022 | $25,997,000 | -28.7% | 558,724 | -12.5% | 0.01% | -21.4% |
| Q2 2022 | $36,451,000 | -18.0% | 638,598 | -15.7% | 0.01% | 0.0% |
| Q1 2022 | $44,426,000 | +100.2% | 757,860 | +19.6% | 0.01% | +100.0% |
| Q4 2021 | $22,186,000 | -7.1% | 633,887 | -1.1% | 0.01% | 0.0% |
| Q3 2021 | $23,889,000 | -15.8% | 640,819 | -7.8% | 0.01% | -12.5% |
| Q2 2021 | $28,360,000 | +9.7% | 694,758 | -8.8% | 0.01% | 0.0% |
| Q1 2021 | $25,847,000 | +4.4% | 761,758 | -2.1% | 0.01% | 0.0% |
| Q4 2020 | $24,750,000 | +21.9% | 778,319 | -1.6% | 0.01% | 0.0% |
| Q3 2020 | $20,298,000 | +15.1% | 791,036 | +15.1% | 0.01% | +14.3% |
| Q2 2020 | $17,636,000 | +98.0% | 687,018 | +18.6% | 0.01% | +75.0% |
| Q1 2020 | $8,907,000 | -24.2% | 579,493 | +69.2% | 0.00% | 0.0% |
| Q4 2019 | $11,753,000 | +551.1% | 342,564 | +41.8% | 0.00% | +300.0% |
| Q3 2019 | $1,805,000 | -77.5% | 241,611 | -60.9% | 0.00% | -66.7% |
| Q2 2019 | $8,024,000 | +531.8% | 618,254 | +1789.2% | 0.00% | -62.5% |
| Q2 2016 | $1,270,000 | +142.8% | 32,726 | +74.1% | 0.01% | +166.7% |
| Q1 2016 | $523,000 | -33.4% | 18,798 | +28.9% | 0.00% | -25.0% |
| Q4 2015 | $785,000 | +17.5% | 14,587 | -12.6% | 0.00% | 0.0% |
| Q3 2015 | $668,000 | – | 16,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |